Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer ...

and that such miRNAs could provide novel targets for cancer therapy (Table 2). The studies described in the sections above have highlighted a range of examples in which miRNA genes are involved or ...

A new University of Cincinnati Cancer Center study has identified a particular strand of microRNA as a promising new target for overcoming breast cancer treatment resistance and improving outcomes.

Lung cancer (LC) is a major global health issue, with high mortality rates and limited therapeutic options. It is primarily categorized into non-small cell lung cancer (NSCLC) and small cell lung ...

such as for the treatment of cancer or for vaccination, require strategies to restrict replication of the virus in order to limit its toxicity 25,26. Figure 1: Using microRNA target sites to ...

In recent years, chemotherapy-induced cardiovascular disease has emerged as a significant cause of mortality among cancer survivors. Anthracyclines, pivotal in treating cancers like breast cancer and ...

A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.

B. miRNA can act as both oncomiRs and tumor suppressors, affecting cancer through various pathways. C. miRNA and epigenetic effects interact to form a miRNA-epigenetic feedback loop, whose ...

An AI-powered blood test for detecting 12 common cancers has been awarded government funding for further clinical trials.

(HealthDay News) — A biomarker consisting primarily of microRNA-based germline biomarkers ... toxicity in patients with prostate cancer, according to a study published online April 7 in Clinical ...

This finding reinforces PROSTOX as a true measure of the biological response to radiation, independent of treatment era or technique, that can identify the safest course of [prostate cancer ...